Get the Stockscreener App
6.73
4.67%
0.30
Trisalus Life Sciences Inc stock is traded at $6.73, with a volume of 74,154.
It is up +4.67% in the last 24 hours and up +43.19% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$6.43
Open:
$6.41
24h Volume:
74,154
Relative Volume:
0.57
Market Cap:
$336.26M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-3.8409
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
+4.02%
1M Performance:
+43.19%
6M Performance:
+30.43%
1Y Performance:
+63.35%
1-Day Range:
$6.41
$6.87
1-Week Range:
$6.06
$7.3195
52-Week Range:
$3.42
$7.3195
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
6.73 | 321.27M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
How TriSalus Life Sciences Inc. stock valuations compare to rivalsWeekly Risk Summary & AI Enhanced Trading Signals - Newser
TriSalus Life Sciences (Nasdaq: TLSI) plans Dec. 15 KOL event on TriNav PED-TAE - Stock Titan
How TriSalus Life Sciences Inc. stock reacts to job market dataPortfolio Value Report & Intraday High Probability Setup Alerts - Newser
Is TriSalus Life Sciences Inc. Equity Warrant stock vulnerable to regulatory risksJobs Report & AI Driven Stock Movement Reports - Newser
Market Overview: Is Rush Enterprises Inc stock ready for breakoutJuly 2025 Trends & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will TriSalus Life Sciences Inc. Equity Warrant stock gain from lower inflationTrade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for growth ETFsJuly 2025 Short Interest & Technical Entry and Exit Tips - Newser
Bond Watch: What valuation multiples suggest for TriSalus Life Sciences Inc. stockMarket Performance Recap & High Accuracy Trade Alerts - BỘ NỘI VỤ
TriSalus Life Sciences (NASDAQ:TLSI) Upgraded by Wall Street Zen to Hold Rating - Defense World
What drives TriSalus Life Sciences Inc Equity Warrant stock priceLarge Cap Stability Picks & Options Trading Analysis Tools - earlytimes.in
This trade activity should not be overlooked: TriSalus Life Sciences Inc (TLSI) - Setenews
TriSalus Life Sciences (NASDAQ:TLSIW) Trading Up 2.5% – Here’s Why - Defense World
TriSalus Life Sciences Hits New 52-Week High at $5.95 - Markets Mojo
TLSI Surges As Trinav XP Launch And Q4 PERIO Results Put Investors On Alert - RTTNews
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - AOL.com
Why TriSalus Life Sciences Inc. Equity Warrant stock appeals to analystsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why hedge funds are buying TriSalus Life Sciences Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Research Analysts Offer Predictions for TLSI FY2026 Earnings - Defense World
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Is TriSalus Life Sciences Inc. stock a dividend growth opportunity2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How strong is TriSalus Life Sciences Inc. Equity Warrant stock revenue growthWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingJuly 2025 Retail & Verified Short-Term Plans - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantVolume Spike & Daily Market Momentum Tracking - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Levels & Low Risk Entry Point Guides - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantOil Prices & Capital Efficient Trading Techniques - newser.com
TriSalus Life Sciences Launches TriNav®? XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery?? - marketscreener.com
What’s next for TriSalus Life Sciences Inc. stock priceBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Trisalus Life Sciences launches Trinav® XP infusion system to expand options for pressure-enabled drug delivery - MarketScreener
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Eagle-Tribune
Waystar Holding Corp. (Nasdaq: WAY) Added to S&P SmallCap 600, Handles $1.8T Claims - Stock Titan
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):